Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
About this item
Full title
Author / Creator
Publisher
England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Integrating artificial intelligence (AI) into clinical trials for inflammatory bowel disease (IBD) has potential to be transformative to the field. This article explores how AI-driven technologies, including machine learning (ML), natural language processing, and predictive analytics, have the potential to enhance important aspects of IBD trials-fr...
Alternative Titles
Full title
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_144af9b10a5c44ab92bd9da5bd590722
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_144af9b10a5c44ab92bd9da5bd590722
Other Identifiers
ISSN
1756-283X,1756-2848
E-ISSN
1756-2848
DOI
10.1177/17562848251321915
